版本:
中国

BRIEF-Delmar Pharmaceuticals collaborates with Duke University to explore VAL-083

April 25 Delmar Pharmaceuticals Inc

* Delmar Pharmaceuticals collaborates with Duke University to explore VAL-083 as a front-line treatment for glioblastoma multiforme

* Delmar pharmaceuticals says it will fund a series of pre-clinical studies to be conducted by Duke University's glioblastoma drug discovery group to evaluate VAL-083 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐